Applicant, as named in the Orange Book

Eli Lilly And Co

Eli Lilly & Co · NYSE: LLY

Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings

Next listed expiry: Verzenio on 28 Sep 2031. 12 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Verzenio NDA 208716 · 4 strengths abemaciclib	abemaciclib	28 Sep 2031 patent	patent
Olumiant NDA 207924 · 3 strengths baricitinib	baricitinib	30 Nov 2032 patent, carve-out possible	patent, carve-out possible
Foundayo NDA 220934 · 6 strengths orforglipron calcium	orforglipron calcium	26 Sep 2037 patent	patent
Retevmo NDA 213246 · 2 strengths selpercatinib	selpercatinib	10 Apr 2039 patent	patent
Retevmo NDA 218160 · 4 strengths selpercatinib	selpercatinib	10 Apr 2039 patent	patent
Inluriyo NDA 218881 imlunestrant tosylate	imlunestrant tosylate	11 Jul 2039 patent	patent
Zepbound NDA 217806 · 12 strengths tirzepatide	tirzepatide	22 Jul 2039 patent, carve-out possible	patent, carve-out possible
Zepbound (Autoinjector) NDA 217806 · 6 strengths tirzepatide	tirzepatide	22 Jul 2039 patent, carve-out possible	patent, carve-out possible
Zepbound Kwikpen NDA 217806 · 6 strengths tirzepatide	tirzepatide	22 Jul 2039 patent, carve-out possible	patent, carve-out possible
Mounjaro NDA 215866 · 12 strengths tirzepatide	tirzepatide	30 Dec 2041 patent, carve-out possible	patent, carve-out possible
Mounjaro (Autoinjector) NDA 215866 · 6 strengths tirzepatide	tirzepatide	30 Dec 2041 patent, carve-out possible	patent, carve-out possible
Mounjaro Kwikpen NDA 215866 · 6 strengths tirzepatide	tirzepatide	30 Dec 2041 patent, carve-out possible	patent, carve-out possible

Verzenio · Generic tentatively approved · ANDA 220238, Qilu Pharmaceutical Co., Ltd.Tentative approval 6 Nov 2025Detected 25 Oct 2026
Zepbound (Autoinjector) · Exclusivity expires within 90 days NPExclusivity expires 8 Nov 2026Detected 24 Oct 2026
Zepbound (Autoinjector) · Exclusivity expires within 90 days NPExclusivity expires 8 Nov 2026Detected 24 Oct 2026
Zepbound (Autoinjector) · Exclusivity expires within 90 days NPExclusivity expires 8 Nov 2026Detected 24 Oct 2026
Zepbound (Autoinjector) · Exclusivity expires within 90 days NPExclusivity expires 8 Nov 2026Detected 24 Oct 2026
Zepbound (Autoinjector) · Exclusivity expires within 90 days NPExclusivity expires 8 Nov 2026Detected 24 Oct 2026
Zepbound (Autoinjector) · Exclusivity expires within 90 days NPExclusivity expires 8 Nov 2026Detected 24 Oct 2026
Axiron · Enters 12-month window basis: patent, carve-out possibleListed date 27 Sep 2027Detected 24 Oct 2026